Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)

BRAF kinase gene V600 point mutations drive approximately 40% to 50% of all melanomas, and BRAF inhibitors (BRAFi) have been found to significantly improve survival outcomes. Although radiation therapy (RT) provides effective symptom palliation, there is a lack of toxicity and efficacy data when RT...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Radiat Oncol Biol Phys
Huvudupphovsmän: Anker, Christopher J., Grossmann, Kenneth F., Atkins, Michael B., Suneja, Gita, Tarhini, Ahmad A., Kirkwood, John M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102246/
https://ncbi.nlm.nih.gov/pubmed/27131079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2016.01.038
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk